Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Better access to primary care physicians may increase high blood pressure awareness and control

Having easier access to primary care physicians may increase high blood pressure awareness and control regardless of where a person lives, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed journal of the American Heart Association.

6 Sep 2022

Study investigates the effect of tRNS in a variety of settings

Though many of us may seek a quiet place in which to study, 'noise' may play a key role in helping some people improve their learning potential.

5 Sep 2022

UTHSC team wins $2.13 million NINDS award to study early neuron development

The National Institute of Neurological Disorders and Stroke has awarded $2.13 million to a University of Tennessee Health Science Center (UTHSC) team studying how neural cells that build a functional brain are generated during embryonic and neonatal life.

2 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

Gene variants associated with blood type may contribute to risk of early stroke

Gene variants associated with a person's blood type may be linked to their risk of early stroke, according to a new meta-analysis published in the August 31, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Sep 2022

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Exploring the muscle symptoms associated with statin therapy

In a new study, investigators explored the influences of statin treatment on muscle symptoms.

31 Aug 2022

Scientists uncover how a build-up of harmful protein starts to happen in Parkinson's disease

Scientists at the Francis Crick Institute, UCL and the University of Edinburgh have uncovered how a build-up of harmful protein starts to happen within neurons in Parkinson's disease, ultimately causing nerve cell death.

30 Aug 2022

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Recent breakthroughs have revealed a great deal about Alzheimer's disease, but researchers have yet to paint a complete picture of how genetic risk for the illness causes the brain damage that ultimately leads to memory loss and cognitive decline.

30 Aug 2022

Study reinforces the potential of Huntington’s treatments that target glia cells

Huntington's disease – a hereditary and fatal genetic disorder – has long been considered a neuronal disease due to the permanent loss of medium spiny motor neurons, the death of which over time is responsible for the clinical hallmarks of the disease: involuntary movements, problems with coordination, cognitive decline, depression, and psychosis.

30 Aug 2022

Researchers identify potential new pathway for treating a sporadic form of ALS

Researchers have published two papers describing how they identified a potential new pathway for treating a sporadic form of amyotrophic lateral sclerosis (ALS).

30 Aug 2022

Higher tea intake linked with modestly lower risk of death

A prospective study of half a million tea drinkers in the United Kingdom has shown that higher tea intake was associated with a modestly lowered risk of death.

29 Aug 2022

Performing moderate or vigorous physical activity may lower the risk of heart failure

A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association's flagship journal Circulation.

29 Aug 2022

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

A new study reviewed evidence from trials and studies to assess the risks and benefits of using statins to prevent or reduce morbidities or mortalities related to cardiovascular disease (CVD).

29 Aug 2022

Association between different physical activities and longevity of elder individuals

Researchers investigated whether different leisure time physical activities (LT-PA) were differentially associated with all-cause mortality and mortality risks from cancer or cardiovascular disorders among elder individuals.

29 Aug 2022

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

A randomized trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower the risk of death, heart attack and stroke in 65 to 69 year-olds.

28 Aug 2022

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

As populations around the globe age, dementia - often caused by Alzheimer's disease and related disorders - is a growing health issue for older adults worldwide.

26 Aug 2022

Stroke News and Research

Further Reading

Better access to primary care physicians may increase high blood pressure awareness and control

Study investigates the effect of tRNS in a variety of settings

UTHSC team wins $2.13 million NINDS award to study early neuron development

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Gene variants associated with blood type may contribute to risk of early stroke

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

The currently available evidence on viral-induced parkinsonism

Exploring the muscle symptoms associated with statin therapy

Scientists uncover how a build-up of harmful protein starts to happen in Parkinson's disease

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Study reinforces the potential of Huntington’s treatments that target glia cells

Researchers identify potential new pathway for treating a sporadic form of ALS

Higher tea intake linked with modestly lower risk of death

Performing moderate or vigorous physical activity may lower the risk of heart failure

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

Association between different physical activities and longevity of elder individuals

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News